Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
NCT00054873 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2006-07-11
Summary
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
Conditions
- Esophageal Neoplasms
- Stomach Neoplasms
- Adenocarcinoma
Interventions
- DRUG
-
tezacitabine
- DRUG
Sponsors & Collaborators
-
Chiron Corporation
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Completion
- 2004-12-31
Countries
- United States
Study Locations
More Related Trials
-
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
NCT00525915 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
NCT00453323 ·Status: UNKNOWN ·Phase: PHASE2
-
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
NCT00230451 ·Status: COMPLETED ·Phase: PHASE2
-
Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
NCT00154700 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
NCT00561197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
NCT00009880 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
NCT00570531 ·Status: TERMINATED ·Phase: PHASE2
-
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
NCT02530437 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
NCT05638984 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
NCT05515315 ·Status: RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00021320 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00281788 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
NCT00008047 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
NCT00006472 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
NCT03784326 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
NCT02762474 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
NCT05628610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
NCT02598687 ·Status: WITHDRAWN ·Phase: PHASE1
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT01561014 ·Status: COMPLETED ·Phase: PHASE1
-
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
NCT07046221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
NCT00416858 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer
NCT00238147 ·Status: COMPLETED ·Phase: PHASE1